Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of oral GKT137831 in type 2 diabetes with albuminuria
2013-002507-34Phase 2Completed
- Sponsor
- Genkyotex
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic glomerulosclerosis and type 2 diabetes mellitus (T2DM) comparing GKT137831 with Placebo (2 arms). Primary endpoint: Change from baseline in urine albumin/creatinine ratio. Started Oct 2013; status: completed.
02
Drugs
setanaxib
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2013-002507-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002507-34.